Comparative nutritional analysis of four commercial infant formulas: compliance with food and drug administration regulations and developmental appropriateness across 0-6 and 6-12-month stages
DOI:
https://doi.org/10.18203/2349-3291.ijcp20261527Keywords:
Infant formula, FDA regulations, DHA, Probiotics, HMOs, Nutritional composition, Developmental stagesAbstract
Background: Infant formula serves as the primary nutritional source for non- breastfed infants, requiring strict adherence to regulatory standards while meeting developmental needs across different age stages. Objectives were to comparatively evaluate four commercially available infant formulas (Nestlé NAN PRO, Similac Advance, Aptamil Gold, and Nestlé Lactogen PRO) against Food and Drug administration (FDA) nutrient specifications and analyze their compositional appropriateness for stage 1 (0-6 months) and stage 2 (6-12 months).
Methods: Label-based comparative analysis of macronutrients, micronutrients, functional lipids Docosahexaenoic acid/ arachidonic acid (DHA/ARA), bioactive components [(probiotics, prebiotics, human milk oligosaccharides (HMOs), and added sugars. All values were normalized per 100 kcal and compared against food and drug administration (FDA) minimum and maximum requirements.
Results: All four formulas met FDA macronutrient specifications. Stage 2 formulations showed 14-48% protein increases and 40-300% sugar increases compared to stage 1. Aptamil Gold demonstrated the most comprehensive functional profile with five HMOs, GOS/FOS prebiotics, and DHA/ARA across both stages. NAN PRO maintained DHA/ARA consistency but discontinued probiotics in stage 2. Similac Advance exhibited the highest added sugar content in stage 2 (30 g/100 g) while retaining milk fat. Lactogen PRO emphasized digestibility through probiotics but lacked long-chain polyunsaturated fatty acids (LC-PUFAs). Iron content across all brands (6.5-9 mg/100 g stage 2) exceeded FDA minimum requirements, appropriately addressing post-6-month Anemia risk.
Conclusions: While all formulas comply with FDA nutrient specifications, significant compositional heterogeneity exists in functional ingredients and added sugars, potentially impacting gut microbiome development, neurocognitive outcomes, and metabolic programming. These findings underscore the importance of evidence-based formula selection aligned with individual infant nutritional needs.
References
Martin CR, Ling PR, Blackburn GL. Review of infant feeding: key features of breast milk and infant formula. Nutrients. 2016;8(5):279.
Ahern GJ, Hennessy AA, Ryan CA, Ross RP, Stanton C. Advances in infant formula science. Annu Rev Food Sci Technol. 2019;10:75-102.
Baker P, Russ K, Kang M, Santos TM, Neves PAR, Smith J, et al. Globalization, first-foods systems transformations and corporate power. Global Health. 2021;17(1):58.
U.S. Food and Drug Administration. 21 CFR Part 107-Infant Formula. Code of Federal Regulations. 2015. Available at: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-B/part-107. Accessed on 15 March 2026.
Innis SM. Palmitic acid in early human development. Crit Rev Food Sci Nutr. 2016;56(12):1952-9.
Vandenplas Y, De Greef E, Veereman G. Prebiotics in infant formula. Gut Microbes. 2014;5(6):681-7.
Bode L. The functional biology of human milk oligosaccharides. Early Hum Dev. 2015;91(11):619-22.
Sung V, D’Amico F, Cabana MD, Kim C, Gideon K, Francesco S, et al. Lactobacillus reuteri to treat infant colic: a meta-analysis. Pediatrics. 2018;141(1):e20171811.
Foiles AM, Kerling EH, Wick JA, Scalabrin DMF, Colombo J, Carlson SE. Formula with long-chain polyunsaturated fatty acids reduces incidence of allergy in early childhood. Pediatr Allergy Immunol. 2016;27(2):156-61.
Indrio F, Di Mauro A, Riezzo G, Elisa C, Cristina I, Luigi C, et al. Prophylactic use of a probiotic in the prevention of colic, regurgitation, and functional constipation: a randomized clinical trial. JAMA Pediatr. 2014;168(3):228-33.
Berger B, Porta N, Foata F, Dominik G, Michèle D, Deborah M, et al. Linking human milk oligosaccharides, infant fecal community types, and later risk to require antibiotics. mBio. 2020;11(2):03196-19.
Carver JD. Advances in nutritional modifications of infant formulas. Am J Clin Nutr. 2003;77(6):1550-4.
Ventura AK, Mennella JA. Innate and learned preferences for sweet taste during childhood. Curr Opin Clin Nutr Metab Care. 2011;14(4):379-84.
Pekmez CT, Dragsted LO, Brahe LK. Gut microbiota alterations and dietary modulation in childhood malnutrition. Clin Nutr. 2019;38(2):615-30.
Domellöf M, Braegger C, Campoy C, Virginie C, Tamas D, Mary F, et al. Iron requirements of infants and toddlers. J Pediatr Gastroenterol Nutr. 2014;58(1):119-29.
Abrams SA. Calcium and vitamin D requirements of enterally fed preterm infants. Pediatrics. 2013;131:1676-83.
Wagner CL, Greer FR. Prevention of rickets and vitamin D deficiency in infants, children, and adolescents. Pediatrics. 2008;122:1142-52.
Lauritzen L, Brambilla P, Mazzocchi A, Harsløf LBS, Ciappolino V, Agostoni C. DHA effects in brain development and function. Nutrients. 2016;8(1):6.
Rubin LP, Chan GM, Barrett-Reis BM, Fulton AB, Hansen RM, Ashmeade TL, et al. Effect of carotenoid supplementation on plasma carotenoids, inflammation and visual development in preterm infants. J Perinatol. 2012;32(6):418-24.
Li F, Wu SS, Berseth CL, Harris CL, Richards JD, Wampler JL, et al. Improved neurodevelopmental outcomes associated with bovine milk fat globule membrane and lactoferrin in infant formula. J Pediatr. 2019;215:24-31.
Lapillonne A, Pastor N, Zhuang W, Scalabrin DMF. Infants fed formula with added long-chain polyunsaturated fatty acids have reduced incidence of respiratory illnesses and diarrhea. BMC Pediatr. 2014;14:168.
Donovan SM, Comstock SS. Human milk oligosaccharides influence neonatal mucosal and systemic immunity. Ann Nutr Metab. 2016;69(2):41-51.
Puccio G, Alliet P, Cajozzo C, Janssens E, Corsello G, Sprenger N, et al. Effects of infant formula with human milk oligosaccharides on growth and morbidity. J Pediatr Gastroenterol Nutr. 2017;64(4):624-31.
Storm HM, Shepard J, Czerkies LM, Kineman B, Cohen SS, Reichert H, et al.: 2’-fucosyllactose is well tolerated in a 100% whey, partially hydrolyzed infant formula with Bifidobacterium lactis: a randomized controlled trial. Glob Pediatr Health. 2019;6:2333794-19833995.
Fabiano V, Indrio F, Verduci E, Calcaterra V, Pop TL, Mari A, et al. Term infant formulas influencing gut microbiota: an overview. Nutrients. 2021;13(12):4200.
Korpela K, Helve O, Kolho KL, Terhi S, Kirsi S, Evgenia D, et al. Maternal fecal microbiota transplantation in cesarean-born infants rapidly restores normal gut microbial development. Cell. 2020;183(2):324-34.
Vos MB, Kaar JL, Welsh JA, Van Horn LV, Feig DI, Anderson CAM, et al. Added sugars and cardiovascular disease risk in children. Circulation. 2017;135(19):1017-34.
Sarkar A, Yoo JY, Valeria Ozorio Dutra S, Morgan KH, Groer M. The association between early-life gut microbiota and long-term health and diseases. J Clin Med. 2021;10(3):459.
Mennella JA, Lukasewycz LD, Castor SM, Beauchamp GK. The timing and duration of a sensitive period in human flavor learning: a randomized trial. Am J Clin Nutr. 2011;93(5):1019-24.
Rinninella E, Cintoni M, Raoul P, Lopetuso LR, Scaldaferri F, Pulcini G, et al. Food components and dietary habits: keys for a healthy gut microbiota composition. Nutrients. 2019;11(10):2393.
Weaver CM, Gordon CM, Janz KF, Kalkwarf HJ, Lappe JM, Lewis R, et al. The National Osteoporosis Foundation’s position statement on peak bone mass development and lifestyle factors: a systematic review and implementation recommendations. Osteoporos Int. 2016;27(4):1281-386.
Bakshi S, Paswan VK, Yadav SP, Bhinchhar BK, Kharkwal S, Rose H, et al. A comprehensive review on infant formula: nutritional and functional constituents, recent trends in processing and its impact on infants’ gut microbiota. Front Nutr. 2023;10:1194679.
Maathuis A, Havenaar R, He T, Bellmann S. Protein digestion and quality of goat and cow milk infant formula and human milk under simulated infant conditions. J Pediatr Gastroenterol Nutr. 2017;65:661-6.
Zenker HE, van Lieshout GAA, van Gool MP, Bragt MCE, Hettinga KA. Lysine blockage of milk proteins in infant formula impairs overall protein digestibility and peptide release. Food Funct. 2020;11:358-69.
Elmhiri G, Mahmood DFD, Niquet-Leridon C, et al. Formula-derived advanced glycation end products are involved in the development of long-term inflammation and oxidative stress in kidney of IUGR piglets. Mol Nutr Food Res. 2015;59(5):939-47.
Gallier S, Vocking K, Post JA, Philippe J, Stephane F, Lydie G, et al. A novel infant milk formula concept: mimicking the human milk fat globule structure. Colloids Surf B Biointerfaces. 2015;136:329-39.
Venema K, Verhoeven J, Verbruggen S. Calcium and phosphorus bioaccessibility from different amino acid-based medical nutrition formulas for infants and children under in vitro digestive conditions. Clin Nutr Exp. 2020;32:20-8.
Lund P, Bechshøft MR, Ray CA, Lund MN. Effect of processing of whey protein ingredient on Maillard reactions and protein structural changes in powdered infant formula. J Agric Food Chem. 2022;70(1):319-32.
Downloads
Published
How to Cite
Issue
Section
